破坏成人珠蛋白启动子缓解启动子竞争并重新激活胎儿珠蛋白基因表达
本研究系统分析遗传性胎儿血红蛋白持续存在(HPFH)及δβ-地中海贫血相关的β-珠蛋白基因簇下游缺失,提出统一机制:胎儿珠蛋白上调时近端成人β-珠蛋白(HBB)启动子均缺失。利用CRISPR基因编辑删除或破坏启动子元件,发现几乎所有降低HBB启动子活性的突变均导致胎儿珠蛋白表达升高,提示靶向HBB启动子可能用于治疗β-血红蛋白病。
要点
- 可缺失型HPFH中胎儿珠蛋白上调时均伴近端成人HBB启动子缺失。
- CRISPR编辑破坏HBB启动子元件可升高胎儿珠蛋白表达。
- 胎儿与成人珠蛋白基因竞争远端基因座控制区,靶向HBB启动子或可治疗β-血红蛋白病。
核心结论
- 可缺失型HPFH和δβ-地中海贫血中胎儿珠蛋白上调的共同机制是近端成人HBB启动子缺失,破坏HBB启动子可升高胎儿珠蛋白表达。
- 作者认为靶向HBB启动子可能作为升高胎儿珠蛋白、降低镰状珠蛋白以治疗β-血红蛋白病的方向进行探索。
研究设计与样本
- 系统分析HPFH及δβ-地中海贫血相关的β-珠蛋白基因簇下游缺失。
- 利用CRISPR介导的基因编辑删除或破坏HBB启动子内元件。
主要发现
- 所有胎儿珠蛋白上调的可缺失型HPFH病例中,近端成人HBB启动子均缺失。
- CRISPR编辑删除或破坏启动子元件后,几乎所有降低HBB启动子活性的突变均导致胎儿珠蛋白表达升高。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The benign condition hereditary persistence of fetal hemoglobin (HPFH) is known to ameliorate symptoms of co-inherited β-hemoglobinopathies, such as sickle cell disease and β-thalassemia. The condition is sometimes associated with point mutations in the fetal globin promoters that disrupt the binding of the repressors BCL11A or ZBTB7A/LRF, which have been extensively studied. HPFH is also associated with a range of deletions within the β-globin locus that all reside downstream of the fetal HBG2 gene. These deletional forms of HPFH are poorly understood and are the focus of this study. Numerous different mechanisms have been proposed to explain how downstream deletions can boost the expression of the fetal globin genes, including the deletion of silencer elements, of genes encoding noncoding RNA, and bringing downstream enhancer elements into proximity with the fetal globin gene promoters. Here we systematically analyze the deletions associated with both HPFH and a related condition known as δβ-thalassemia and propose a unifying mechanism. In all cases where fetal globin is upregulated, the proximal adult β-globin (HBB) promoter is deleted. We use clustered regularly interspaced short palindromic repeats-mediated gene editing to delete or disrupt elements within the promoter and find that virtually all mutations that reduce ΗΒΒ promoter activity result in elevated fetal globin expression. These results fit with previous models where the fetal and adult globin genes compete for the distal locus control region and suggest that targeting the ΗΒΒ promoter might be explored to elevate fetal globin and reduce sickle globin expression as a treatment of β-hemoglobinopathies.
引用
- Topfer SK, Feng R, Huang P, et al. Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression. Blood. 2022. PMID: 35090172. doi:10.1182/blood.2021014205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。